Opening book details…
Can I read Improving Anti-angiogenic Therapy via Selective Delivery of Cationic Liposomes to Tumour Vasculature on EtoBox?
Improving Anti-angiogenic Therapy via Selective Delivery of Cationic Liposomes to Tumour Vasculature by Crispin R. Dass is a Pharmacology, Toxicology and Pharmaceutics article available to read on EtoBox.
What is Improving Anti-angiogenic Therapy via Selective Delivery of Cationic Liposomes to Tumour Vasculature about?
In the past three decades, two very important findings regarding tumour vasculature have been made. Firstly, it has been known a solid tumour has to establish an adequate blood supply to grow beyond a critical mass. Secondly, it has been proven that the tumour vasculature is relatively more aberrant, dynamic and permeable than healthy host tissue. This review discusses the potential of delivering therapeutic nucleic acids to tumour vasculature using cationic liposomes, vehicles recently demonstrated to be selectively delivered to tumour vasculature.
Who reads Improving Anti-angiogenic Therapy via Selective Delivery of Cationic Liposomes to Tumour Vasculature?
It is typically read by researchers, students, and practitioners in Pharmacology, Toxicology and Pharmaceutics.
- Author
- Crispin R. Dass
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV (ISSN 0378-5173)
- Published
- 2003
- Language
- EN
- Field
- Pharmacology, Toxicology and Pharmaceutics (Life Sciences)